{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T08:50:20Z","timestamp":1713171020100},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.rmr.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T19:59:01Z","timestamp":1536695941000},"page":"785-787","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["L\u2019infection tuberculeuse latente, du diagnostic au pronostic"],"prefix":"10.1016","volume":"35","author":[{"given":"P.","family":"Fraisse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2018.07.004_bib0105","series-title":"Updated and consolidated guidelines for programmatic management. WHO\/CDS\/TB\/2018.9","first-page":"1","article-title":"Latent tuberculosis infection","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.rmr.2018.07.004_bib0110","series-title":"Collection Avis et Rapports","first-page":"1","article-title":"Groupe de travail de la Commission sp\u00e9cialis\u00e9e des maladies transmissibles. Tuberculose et tests de d\u00e9tection de l\u2019interf\u00e9ron gamma","author":"Haut Conseil de la sant\u00e9, publique","year":"2011"},{"key":"10.1016\/j.rmr.2018.07.004_bib0115","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosisinfection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2018.07.004_bib0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)30436-2","article-title":"Safety and efficacy of the C-TB skin test to diagnose Mycobacterium tuberculosisinfection, compared with an interferon gamma release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial","volume":"5","author":"Ruhwald","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmr.2018.07.004_bib0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.20411\/pai.v1i2.173","article-title":"Clinical application of interferon-gamma release assays for the prevention of tuberculosis in countries with low incidence","volume":"1","author":"Lange","year":"2016","journal-title":"Pathog Immun"},{"key":"10.1016\/j.rmr.2018.07.004_bib0130","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1164\/rccm.201502-0232OC","article-title":"Risk assessment of tuberculosis in contacts by IFN-gamma release assays. A Tuberculosis Network European Trials Group study","volume":"191","author":"Zellweger","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2018.07.004_bib0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2018.07.004_bib0140","first-page":"121","article-title":"Les activit\u00e9s de ma\u00eetrise de la tuberculose men\u00e9es par les Centres de lutte antituberculeuse. Bilan en 2016\u00a0et perspectives","author":"Lailler","year":"2018","journal-title":"Bull Epidemiol Hebd"},{"key":"10.1016\/j.rmr.2018.07.004_bib0145","first-page":"1374","article-title":"Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review","volume":"14","author":"Kunst","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.rmr.2018.07.004_bib0150","first-page":"1138","article-title":"Latent tuberculosis infection screening and 2-year outcome in antiretroviral-naive HIV-infected patients in a low-prevalence country","volume":"12","author":"Bourgarit","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmr.2018.07.004_bib0155","series-title":"\u00c9laboration de recommandations de bonne pratique - m\u00e9thode- \u00ab\u00a0recommandations par consensus formalis\u00e9\u00a0\u00bb (mise \u00e0 jour mars 2015)","first-page":"1","author":"Haute autorit\u00e9 de sant\u00e9,","year":"2010"},{"key":"10.1016\/j.rmr.2018.07.004_bib0160","series-title":"\u00c9laboration de recommandations relatives \u00e0 la bonne pratique. Note de cadrage (mise \u00e0 jour d\u00e9cembre 2014)","first-page":"1","author":"Haute autorit\u00e9 de sant\u00e9,","year":"2010"},{"key":"10.1016\/j.rmr.2018.07.004_bib0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","article-title":"Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis","volume":"17","author":"Auguste","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.rmr.2018.07.004_bib0170","series-title":"Niveau de preuve et gradation des recommandations de bonne pratique","first-page":"1","author":"Haute autorit\u00e9 de sant\u00e9,","year":"2013"},{"key":"10.1016\/j.rmr.2018.07.004_bib0175","first-page":"1","author":"Haute autorit\u00e9 de sant\u00e9,","year":"2015"},{"key":"10.1016\/j.rmr.2018.07.004_bib0180","series-title":"Guidelines on the management of latent tuberculosis infection","first-page":"1","author":"World Health, Organization","year":"2015"},{"key":"10.1016\/j.rmr.2018.07.004_bib0185","series-title":"Commission de la transparence. Avis du 7\u00a0octobre 2015","first-page":"1","article-title":"Tubertest solution injectable, d\u00e9riv\u00e9 prot\u00e9inique purifi\u00e9 de tuberculine","author":"Haute autorit\u00e9 de sant\u00e9,","year":"2015"},{"key":"10.1016\/j.rmr.2018.07.004_bib0190","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2018.07.004_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmr.2017.09.008","article-title":"Lutte antituberculeuse\u00a0: la courbe des d\u00e9cideurs","volume":"35","author":"Fraisse","year":"2018","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2018.07.004_bib0100","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201711-2340OC","article-title":"Four-gene pan-African blood signature predicts progression to tuberculosis","volume":"197","author":"Suliman","year":"2018","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518302857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518302857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T18:22:00Z","timestamp":1539195720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842518302857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0761842518302857"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2018.07.004","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L\u2019infection tuberculeuse latente, du diagnostic au pronostic","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}